16.5 lakh vials of Remdesivir allocated to states between May 3-May 9: Centre ANI | Updated: May 05, 2021 17:10 IST
New Delhi [India], May 5 (ANI): The Centre on Wednesday informed that 16.5 lakh vials of Remdesivir were allocated to states between May 3 and May 9 , in wake of the Covid-19 pandemic. Union Minister of Chemicals and Fertilisers, DV Sadananda Gowda chaired a meeting to review the availability of drugs for Covid treatment and other essential drugs , informed an official release by the Ministry of Chemicals and Fertilizers.
Gowda during the meeting appreciated the efforts of all seven manufacturers of Remdesivir for increasing the production capacity to 1.03 crore vials per month, up from 38 lakh vials per month a month ago. This increased capacity will augment the domestic availability of the injection.
Daily new cases continue to plateau in 12 States: Health Ministry
May 05, 2021
Inter-ministerial panel looking at deployment of aid received from foreign countries, says official
There continues to be a plateauing in daily Covid-19 cases in 12 States in the last 14 days, Health Ministry data showed. These States are Maharashtra, Uttar Pradesh, Delhi, Chhattisgarh, Gujarat, Madhya Pradesh, Telangana, Jharkhand, Daman & Diu, Ladakh, Lakshadweep and Andaman & Nikobar. However, Health Ministry official Lav Agarwal said this is not the time to loosen up seeing the early decline as it may cost dearly to the country, going forward.
“In the case of infections, even a single day laxity may squander the efforts made to come to a low level of Coronavirus cases. That’s why there is a need to make continuous efforts towards containing the further spread,” said Agarwal, who is a Joint Secretary in the Health Ministry.
NEW DELHI: Black marketing of critical Covid-19 drugs and oxygen is a condemnable attempt to exploit peoples misery, the Supreme Court has said, directing the Centre to consider constituting a special team to identify and prosecute offenders.
The apex court also said that a protocol must be evolved for ambulances to avoid extraction of unconscionable charges from citizens and the Centre can consider creating a platform for easy reporting and redressal of such cases.
A bench headed by Justice D Y Chandrachud noted that several critical drugs such as Remdesivir and Tocilizumab, are being sold at significantly inflated prices or in fake form.